Medicinal composition for treating skin diseases

A composition and technology for skin diseases, applied in the field of pharmaceutical compositions for treating skin diseases, can solve the problems of large irritation type, gastrointestinal irritation, slow curative effect, etc. Effect

Inactive Publication Date: 2011-06-22
孙洪恩
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among the Chinese patent medicines for the treatment of skin diseases, the oral preparations all taste bitter and have a certain stimulating effect on the gastrointestinal tract, while the external Chinese patent medicine preparations are more irritating to the skin, especially children’s skin, and the curative effect is slow and weak

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating skin diseases
  • Medicinal composition for treating skin diseases
  • Medicinal composition for treating skin diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] The preparation of embodiment 1 powder

[0019] A powder pharmaceutical composition for treating skin diseases, consisting of benzoic acid, boric acid, salicylic acid, nitrofurazone, flavescens and alum, in parts by weight: 50 parts of benzoic acid, 50 parts of boric acid, 26 parts of salicylic acid 1 part, 1 part of nitrofurazone, 13 parts of Sophora flavescens, 5 parts of dried alum. Mix and grind the prescribed amount of traditional Chinese medicine raw materials to make powder, stir evenly, and sieve to obtain drug powder powder, which is packed in 13-17g / bag.

Embodiment 2

[0020] The preparation of embodiment 2 powder

[0021] A powder pharmaceutical composition for treating skin diseases, consisting of benzoic acid, boric acid, salicylic acid, nitrofurazone, flavescens and alum, in parts by weight: 45 parts of benzoic acid, 45 parts of boric acid, 20 parts of salicylic acid 0.5 parts of nitrofurazone, 10 parts of Sophora flavescens, and 2 parts of dried alum. Mix and grind the prescribed amount of traditional Chinese medicine raw materials to make powder, stir evenly, and sieve to obtain drug powder powder, which is packed in 13-17g / bag.

Embodiment 3

[0022] The preparation of embodiment 3 powder

[0023] A liniment pharmaceutical composition for treating skin diseases, which is composed of benzoic acid, boric acid, salicylic acid, nitrofurazone, flavescens and alum, in parts by weight: 55 parts of benzoic acid, 60 parts of boric acid, salicylic acid 30 parts, 2.5 parts of nitrofurazone, 20 parts of Sophora flavescens, 10 parts of dried alum. Mix and grind the prescribed amount of traditional Chinese medicine raw materials to make powder, stir evenly, and sieve to obtain drug powder powder, which is packed in 13-17g / bag.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicinal composition for treating skin diseases, which comprises the following active ingredients in part by weight: 45 to 55 parts of benzoic acid, 45 to 60 parts of boric acid, 20 to 30 parts of salicylic acid, 0.5 to 2.5 parts of furacilin, 10 to 20 parts of lightyellow sophora root and 2 to 10 parts of dehydrated alum. During the treatment of the skin diseases, the invention has the advantages that (1) the medicinal composition is superactive and bactericidal, has quick response and high cure rate and can prevent relapse; (2) sterilization, itching relieving, pain relieving, hidroschesis and podobromidrosis removal are realized simultaneously; (3) dosage is little; and (4) the safety is high.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating skin diseases, in particular to a pharmaceutical composition for treating athlete's foot, tinea manuum, jock itch, sweat spots and onychomycosis. Background technique [0002] There are many types of skin diseases, most of which are caused by skin infections or allergies. Athlete's foot, tinea manuum, jock itch, sweat spot, onychomycosis (commonly known as onychomycosis) are the most common skin diseases, the cause of disease comes from the fungus invading the patient's epidermis, parasitizing in the epidermis and forming red pustules, which may appear after scratching. recurrent infection. Take athlete's foot as an example, "Modern Dermatology Therapeutics" (People's Military Medical Press, 1994 edition) is divided into five types of athlete's foot: 1, blister type. Clusters of fire and scattered blisters often occur on the toes and the edges of the feet. The walls of the blisters ar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/489A61P17/00A61P31/10A61K31/192A61K31/345A61K31/60A61K33/06A61K33/22
Inventor 孙洪恩
Owner 孙洪恩
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap